<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title38.html">
                                    Title 38
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/38CFR4.html">Part 4
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  4.116  Schedule of ratings--gynecological conditions and disorders 
------------------------------------------------------------------------
                            </h3>
                            <p class="depth0">Rating------------------------------------------------------------------------</p><p class="depth0">Note 1: Natural menopause, primary amenorrhea, and</p><p class="depth0">pregnancy and childbirth are not disabilities for rating</p><p class="depth0">purposes. Chronic residuals of medical or surgical</p><p class="depth0">complications of pregnancy may be disabilities for rating</p><p class="depth0">purposes.</p><p class="depth0">Note 2: When evaluating any claim involving loss or loss of</p><p class="depth0">use of one or more creative organs or anatomical loss of</p><p class="depth0">one or both breasts, refer to Sec.   3.350 of this chapter</p><p class="depth0">to determine whether the veteran may be entitled to</p><p class="depth0">special monthly compensation. Footnotes in the schedule</p><p class="depth0">indicate conditions which potentially establish</p><p class="depth0">entitlement to special monthly compensation; however,</p><p class="depth0">almost any condition in this section might, under certain</p><p class="depth0">circumstances, establish entitlement to special monthly</p><p class="depth0">compensation.7610 Vulva, disease or injury of (including vulvovaginitis).7611 Vagina, disease or injury of.7612 Cervix, disease or injury of.7613 Uterus, disease, injury, or adhesions of.7614 Fallopian tube, disease, injury, or adhesions of</p><p class="depth0">(including pelvic inflammatory disease (PID)).7615 Ovary, disease, injury, or adhesions of.General Rating Formula for Disease, Injury, or Adhesions of</p><p class="depth0">Female Reproductive Organs (diagnostic codes 7610 through</p><p class="depth0">7615):</p><p class="depth0">Symptoms not controlled by continuous treatment............       30</p><p class="depth0">Symptoms that require continuous treatment.................       10</p><p class="depth0">Symptoms that do not require continuous treatment..........        07617 Uterus and both ovaries, removal of, complete:</p><p class="depth0">For three months after removal.............................  \1\ 100</p><p class="depth0">Thereafter.................................................   \1\ 507618 Uterus, removal of, including corpus:</p><p class="depth0">For three months after removal.............................  \1\ 100</p><p class="depth0">Thereafter.................................................   \1\ 307619 Ovary, removal of:</p><p class="depth0">For three months after removal.............................  \1\ 100</p><p class="depth0">Thereafter:</p><p class="depth0">Complete removal of both ovaries.......................   \1\ 30</p><p class="depth0">Removal of one with or without partial removal of the      \1\ 0</p><p class="depth0">other.................................................7620 Ovaries, atrophy of both, complete........................   \1\ 207621 Uterus, prolapse:</p><p class="depth0">Complete, through vagina and introitus.....................       50</p><p class="depth0">Incomplete.................................................       307622 Uterus, displacement of:</p><p class="depth0">With marked displacement and frequent or continuous               30</p><p class="depth0">menstrual disturbances....................................</p><p class="depth0">With adhesions and irregular menstruation..................       107623 Pregnancy, surgical complications of:</p><p class="depth0">With rectocele or cystocele................................       50</p><p class="depth0">With relaxation of perineum................................       107624 Fistula, rectovaginal:</p><p class="depth0">Vaginal fecal leakage at least once a day requiring wearing      100</p><p class="depth0">of pad....................................................</p><p class="depth0">Vaginal fecal leakage four or more times per week, but less       60</p><p class="depth0">than daily, requiring wearing of pad......................</p><p class="depth0">Vaginal fecal leakage one to three times per week requiring       30</p><p class="depth0">wearing of pad............................................</p><p class="depth0">Vaginal fecal leakage less than once a week................       10</p><p class="depth0">Without leakage............................................        07625 Fistula, urethrovaginal:</p><p class="depth0">Multiple urethrovaginal fistulae...........................      100</p><p class="depth0">Requiring the use of an appliance or the wearing of               60</p><p class="depth0">absorbent materials which must be changed more than four</p><p class="depth0">times per day.............................................</p><p class="depth0">Requiring the wearing of absorbent materials which must be        40</p><p class="depth0">changed two to four times per day.........................</p><p class="depth0">Requiring the wearing of absorbent materials which must be        20</p><p class="depth0">changed less than two times per day.......................7626 Breast, surgery of:</p><p class="depth0">Following radical mastectomy:</p><p class="depth0">Both...................................................    \1\80</p><p class="depth0">One....................................................    \1\50</p><p class="depth0">Following modified radical mastectomy:</p><p class="depth0">Both...................................................    \1\60</p><p class="depth0">One....................................................    \1\40</p><p class="depth0">Following simple mastectomy or wide local excision with</p><p class="depth0">significant alteration of size or form:</p><p class="depth0">Both...................................................    \1\50</p><p class="depth0">One....................................................    \1\30</p><p class="depth0">Following wide local excision without significant</p><p class="depth0">alteration of size or form:</p><p class="depth0">Both or one............................................        0</p><p class="depth0">Note: For VA purposes:</p><p class="depth1"><em>(1)</em> Radical mastectomy means removal of the entire</p><p class="depth2">breast, underlying pectoral muscles, and regional</p><p class="depth2">lymph nodes up to the coracoclavicular ligament.......</p><p class="depth1"><em>(2)</em> Modified radical mastectomy means removal of the</p><p class="depth2">entire breast and axillary lymph nodes (in continuity</p><p class="depth2">with the breast). Pectoral muscles are left intact....</p><p class="depth1"><em>(3)</em> Simple (or total) mastectomy means removal of all</p><p class="depth2">of the breast tissue, nipple, and a small portion of</p><p class="depth2">the overlying skin, but lymph nodes and muscles are</p><p class="depth2">left intact...........................................</p><p class="depth1"><em>(4)</em> Wide local excision (including partial mastectomy,</p><p class="depth2">lumpectomy, tylectomy, segmentectomy, and</p><p class="depth2">quadrantectomy) means removal of a portion of the</p><p class="depth2">breast tissue.........................................7627 Malignant neoplasms of gynecological system or breast.....      100</p><p class="depth2">Note: A rating of 100 percent shall continue beyond the</p><p class="depth2">cessation of any surgical, X-ray, antineoplastic</p><p class="depth2">chemotherapy or other therapeutic procedure. Six months</p><p class="depth2">after discontinuance of such treatment, the appropriate</p><p class="depth2">disability rating shall be determined by mandatory VA</p><p class="depth2">examination. Any change in evaluation based upon that or</p><p class="depth2">any subsequent examination shall be subject to the</p><p class="depth2">provisions of Sec.   3.105(e) of this chapter. If there</p><p class="depth2">has been no local recurrence or metastasis, rate on</p><p class="depth2">residuals.7628 Benign neoplasms of the gynecological system or breast.</p><p class="depth2">Rate according to impairment in function of the urinary or</p><p class="depth2">gynecological systems, or skin.7629 Endometriosis:</p><p class="depth2">Lesions involving bowel or bladder confirmed by                   50</p><p class="depth2">laparoscopy, pelvic pain or heavy or irregular bleeding</p><p class="depth2">not controlled by treatment, and bowel or bladder symptoms</p><p class="depth2">Pelvic pain or heavy or irregular bleeding not controlled         30</p><p class="depth2">by treatment..............................................</p><p class="depth2">Pelvic pain or heavy or irregular bleeding requiring              10</p><p class="depth2">continuous treatment for control..........................</p><p class="depth2">Note: Diagnosis of endometriosis must be substantiated by</p><p class="depth2">laparoscopy.------------------------------------------------------------------------\1\ Review for entitlement to special monthly compensation under Sec.</p><p class="depth2">3.350 of this chapter.

[60 FR 19855, Apr. 21, 1995, as amended at 67 FR 6874, Feb. 14, 2002; 67 FR 37695, May 30, 2002]</p><p class="depth2">The Hemic and Lymphatic Systems</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
